1
|
Ye XP, Hu YY, Chen YX, Tang ZX, Jiang ZB, Fu Y, Wang ZX, Pi EX, Bian GF, Shi LE. Flavonoids from the genus Polygonatum: biological activities and biosynthesis mechanism. Front Nutr 2025; 12:1574182. [PMID: 40276535 PMCID: PMC12018238 DOI: 10.3389/fnut.2025.1574182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2025] [Accepted: 03/28/2025] [Indexed: 04/26/2025] Open
Abstract
The genus Polygonatum is a medicinal plant that has been used as food for a long time, containing various biologically active compounds, including polysaccharides, saponins, flavonoids, alkaloids, and many others. Polygonatum, like other Chinese herbal plants, can be employed as natural medicines, exhibiting a reduced incidence of adverse effects compared to synthetic pharmaceuticals. Flavonoids are key biomarkers that indicate the quality of the genus Polygonatum, and constitute one of the primary active ingredients. Additionally, flavonoids exhibit a range of nutritional, biological and health-promoting characteristics, including antibacterial, antioxidant, anti-inflammatory, antitumor, and hypoglycemic properties. This paper reviewed biosynthesis and bioactivities of flavonoids from the genus Polygonatum. We hope that this paper would ultimately serve as a valuable reference for the development of flavonoid-related functional foods from the genus Polygonatum.
Collapse
Affiliation(s)
- Xin-Pei Ye
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Yan-Yu Hu
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Yan-Xi Chen
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Zhen-Xing Tang
- School of Culinary Art, Tourism College of Zhejiang, Hangzhou, Zhejiang, China
| | - Zhong-Bao Jiang
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Yue Fu
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Zi-Xin Wang
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Er-Xu Pi
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Gao-Feng Bian
- College of Material, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Material of Education, Hangzhou Normal University, Hangzhou, Zhejiang, China
| | - Lu-E Shi
- Department of Biotechnology, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China
| |
Collapse
|
2
|
Bakrim S, Elouafy Y, Touhtouh J, Aanniz T, El Kadri K, Khalid A, Fawzy S, Mesaik MA, Lee LH, Chamkhi I, Bouyahya A. Exploring the chemistry, biological effects, and mechanism insights of natural coumaroyltyramine: First report. Fitoterapia 2024; 178:106182. [PMID: 39153554 DOI: 10.1016/j.fitote.2024.106182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2024] [Revised: 08/05/2024] [Accepted: 08/10/2024] [Indexed: 08/19/2024]
Abstract
Today, pharmaceutical drugs have been shown to have serious side effects, while the bioactive components of botanical plants are proven to be effective in the treatment of several diseases marked by enhanced oxidative stress and mild inflammation, often associated with minimal adverse events. Coumaroyltyramine, designated by various nomenclatures such as paprazine, N-p-trans-coumaroyltyramine, p-coumaroyltyramine and N-p-coumaroyltyramine, could be a promising bioactive ingredient to address health issues thanks to its powerful anti-inflammatory and antioxidant effects. This review represents the first in-depth analysis of coumaroyltyramine, an intriguing phenylpropanoid substance found in many species of plants. In fact, an in-depth examination of coumaroyltyramine's biological characteristics, chemical attributes, and synthesis process has been undertaken. All previous research relating to the discovery, extraction, biosynthesis, and characterization of the biologically and pharmacologically active properties of coumaroyltyramine has been reviewed and taken into consideration in this analysis. All articles published in a peer-reviewed English-language journal were examined between the initial compilations of the appropriate database until February 12, 2024. A variety of phytochemicals revealed that coumaroyltyramine is a neutral amide of hydroxycinnamic acid that tends to concentrate in plants as a reaction against infection caused by pathogens and is extracted from several medicinal herbs such as Cannabis sativa, Solanum melongena, Allium bakeri, Annona cherimola, Polygonatum zanlanscianense, and Lycopersicon esculentum. Thanks to its effectiveness in suppressing the effect of the enzyme α-glucosidase, coumaroltyramine has demonstrated antihyperglycemic activity and could have an impact on diabetes and metabolic disorders. It has considerable anti-inflammatory and antioxidant effects. These results were obtained through biological and pharmacological studies in silico, in vivo, and in vitro. In addition, coumaroyltyramine has demonstrated hypocholesterolemic and neuroprotective benefits, thereby diminishing heart and vascular disease incidence and helping to prevent neurological disorders. Other interesting properties of coumaroltyramine include anticancer, antibacterial, anti-urease, antifungal, antiviral, and antidysmenorrheal activities. Targeted pathways encompass activity at different molecular levels, notably through induction of endoplasmic reticulum stress-dependent apoptosis, arrest of the cell cycle, and inhibition of the growth of cancer cells, survival, and proliferation. Although the findings from in silico, in vivo, and in vitro experiments illustrate coumaroyltyramine's properties and modes of action, further research is needed to fully exploit its therapeutic potential. To improve our understanding of the compound's pharmacodynamic effects and pharmacokinetic routes, large-scale research should first be undertaken. To determine whether coumaroyltyramine is clinically safe and effective, further studies are required in the clinical and toxicological fields. This upcoming research will be crucial to achieving the overall potency of this substance as a natural drug and in terms of its potential synergies with other drugs.
Collapse
Affiliation(s)
- Saad Bakrim
- Geo-Bio-Environment Engineering and Innovation Laboratory, Molecular Engineering, Biotechnology and Innovation Team, Polydisciplinary Faculty of Taroudant, Ibn Zohr University, Agadir 80000, Morocco.
| | - Youssef Elouafy
- Laboratory of Materials, Nanotechnology and Environment LMNE, Faculty of Sciences, Mohammed V University in Rabat, Rabat BP 1014, Morocco.
| | - Jihane Touhtouh
- Natural Resources and Environment Laboratory, Multidisciplinary Faculty of Taza, Sidi Mohammed Ben Abdellah University, Fez 30000, Morocco
| | - Tarik Aanniz
- Medical Biotechnology Laboratory, Rabat Medical & Pharmacy School, Mohammed V University in Rabat, Rabat B.P. 6203, Morocco.
| | - Kawtar El Kadri
- Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.
| | - Asaad Khalid
- Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan, Saudi Arabia.
| | - Shereen Fawzy
- Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, P.O. Box 741, Tabuk 71491, Saudi Arabia.
| | - M Ahmed Mesaik
- Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, P.O. Box 741, Tabuk 71491, Saudi Arabia.
| | - Learn-Han Lee
- Microbiome Research Group, Research Centre for Life Science and Healthcare, Nottingham Ningbo China Beacons of Excellence Research and Innovation Institute (CBI), University of Nottingham Ningbo China, 315000 Ningbo, China; Novel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor 47500, Malaysia.
| | - Imane Chamkhi
- Geo-Biodiversity and Natural Patrimony Laboratory (GeoBio), Geophysics, Natural Patrimony. Research Center (GEOPAC), Scientific Institute, Mohammed V University in Rabat, Morocco.
| | - Abdelhakim Bouyahya
- Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.
| |
Collapse
|
3
|
Xiaojuan L, Hongmei L, Zhuxin W, Xiaoqin L, Lanbing D, Dan L, Yi Z. Exploration of the pharmacological components and therapeutic mechanisms in treatment of Alzheimer's disease with Polygonati Rhizoma and its processed product using combined analysis of metabolomics, network pharmacology, and gut microbiota. Heliyon 2024; 10:e35394. [PMID: 39170207 PMCID: PMC11336570 DOI: 10.1016/j.heliyon.2024.e35394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2024] [Revised: 06/20/2024] [Accepted: 07/28/2024] [Indexed: 08/23/2024] Open
Abstract
Polygonati Rhizoma (PR, Huangjing in Chinese) and its processed product (PRP), which are used in Traditional Chinese medicine (TCM) for cognitive enhancement and treatment of Alzheimer's disease (AD), have not been fully explored in terms of the different mechanisms underlying their anti-AD effects. Therefore, we used APP/PS1 mice as an AD model to assess the effects of PR and PRP on anxiety-like behaviors, cognitive function, memory performance, and pathological changes in the murine brain. UPLC-HRMS was applied to identify the components of PR and PRP that entered into the blood and brain. Network pharmacology was used to elucidate potential mechanisms underlying the improvement of AD. Differences in the intestinal flora composition between mice treated with PR and PRP were investigated using 16S rRNA sequencing, establishing a correlation between pharmacological components and distinct flora profiles. The results revealed that both PR and PRP interventions ameliorated cognitive deficits and attenuated Amyloid β (Aβ) plaque deposition in the brains of AD mice. Seven specific blood-entering components, namely glutamic acid, Phe-Phe, and uridine, etc., were associated with PR intervention, whereas ten specific blood-entering components including (2R,3S)-3-isopropylmalate, 3-methylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione, and 3-methoxytyrosine were related to PRP intervention. Uridine was identified as a common brain-penetrating component in both PR and PRP interventions. Network pharmacology analysis suggested that the NOD-like receptor signaling pathway, Calcium signaling pathway and Alzheimer's disease were specific pathways targeted in AD treatment using PR intervention. Moreover, the apoptosis pathway was specifically linked to AD treatment during PRP intervention. Furthermore, the administration of both PR and PRP enhanced the abundance and diversity of the intestinal flora in APP/PS1 mice. Western blotting confirmed that PR excels in regulates inflammation, whereas PRP balances autophagy and apoptosis to alleviate the progression of AD. This study offers valuable insights and establishes a robust foundation for further comprehensive exploration of the intrinsic correlation between TCM and AD.
Collapse
Affiliation(s)
- Liao Xiaojuan
- The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410005, China
| | - Liu Hongmei
- The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410005, China
| | - Wang Zhuxin
- The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410005, China
| | - Liu Xiaoqin
- College of Pharmacy, Shandong Modern University, Jinan, 250104, China
| | - Deng Lanbing
- The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410005, China
| | - Luo Dan
- The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410005, China
| | - Zhou Yi
- The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410005, China
| |
Collapse
|
4
|
Liu R, Zhang X, Cai Y, Xu S, Xu Q, Ling C, Li X, Li W, Liu P, Liu W. Research progress on medicinal components and pharmacological activities of polygonatum sibiricum. JOURNAL OF ETHNOPHARMACOLOGY 2024; 328:118024. [PMID: 38484952 DOI: 10.1016/j.jep.2024.118024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 02/22/2024] [Accepted: 03/05/2024] [Indexed: 04/14/2024]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Polygonatum sibiricum, commonly known as Siberian Solomon's seal, is a traditional herb widely used in various traditional medical systems, especially in East Asia. In ancient China, the use of polygonatum sibiricum in medicine and food was mentioned in Li Shizhen's Bencao Gangmu of traditional Chinese medicine (TCM). It was also used in history of India in Vedic medicine. The plant is rich in bioactive substances such as polysaccharides, saponins, flavonoid and alkaloids. AIM OF THE REVIEW The aim of this review is to understand the pharmacological and pharmacokinetics research progress of the major components of polygonatum sibiricum, and to prospect its potential application and development in the treatment of various diseases. MATERIALS AND METHODS We conducted a systematic literature search against major online databases on the Web, including PubMed, ancient books, patents, PubMed, Wiley, Google Scholar, Web of Science, and others. We select the pharmacological process and mechanism of the main components of polygonatum sibiricum in a variety of diseases, and make a strict but careful supplement and in-depth elaboration to this review. RESULTS Several studies have demonstrated the strong antioxidant properties of polygonatum extract, which can be attributed to the presence of flavonoids and other polyphenol compounds; for diabetes and other metabolic-related diseases, polygonatum saponins have particular advantages in regulating intestinal flora and lipoprotein concentration in organisms. In addition, the polysaccharides extracted from this plant have a strong anti-inflammatory effect, which is related to its ability to regulate proinflammatory cytokine and mediators. In the aspect of anti-tumor effect, polygonatum derivatives can induce cancer cell apoptosis mainly by adjusting the cell membrane potential and cell cycle. It is worth noting that the combined action of the main components of polygonatum also offers promising solutions for the treatment of the disease. CONCLUSION Polygonatum polysaccharide has therapeutic effects on many diseases by adjusting cell signal pathways, polygonatum sibiricum have significant advantages in regulating intestinal flora, inducing apoptosis of tumor cells, activating antioxidant processes, etc. Further research and basic exploration are needed to prove the function and mechanisms of the main components of polygonatum sibiricum on related diseases. The study on the immunomodulatory properties of polygonatum revealed its potentiality of enhancing immune function, which made it an interesting subject for further exploration in the field of immunotherapy.
Collapse
Affiliation(s)
- Ruilian Liu
- Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China; The Hospital Affiliated to Hunan Academy of Chinese Medicine, Changsha, 410006, Hunan Province, PR China; Hunan Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| | - Xili Zhang
- Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China; Hunan Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| | - Yuhan Cai
- Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China; Hunan Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| | - Shuang Xu
- The Hospital Affiliated to Hunan Academy of Chinese Medicine, Changsha, 410006, Hunan Province, PR China.
| | - Qian Xu
- The Hospital Affiliated to Hunan Academy of Chinese Medicine, Changsha, 410006, Hunan Province, PR China.
| | - Chengli Ling
- The Hospital Affiliated to Hunan Academy of Chinese Medicine, Changsha, 410006, Hunan Province, PR China.
| | - Xin Li
- Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| | - Wenjiao Li
- Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China; Hunan Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| | - Pingan Liu
- Hunan Academy of Chinese Medicine, Changsha, 410013, Hunan Province, PR China; Hunan Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| | - Wenlong Liu
- Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China; Hunan Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Hunan Province, PR China.
| |
Collapse
|
5
|
Nong Y, Zhou X, Li S, Liu Q, Zhang Y, Liang J, Zhang Y, Liu C. Efficient and fast screening and separation based on computer-aided screening and complex chromatography methods for lipoxygenase inhibitors from Ganoderma lucidum. PHYTOCHEMICAL ANALYSIS : PCA 2024; 35:599-616. [PMID: 38287705 DOI: 10.1002/pca.3316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 12/06/2023] [Accepted: 12/07/2023] [Indexed: 01/31/2024]
Abstract
INTRODUCTION Accurate screening and targeted preparative isolation of active substances from natural medicines have long been technical challenges in natural medicine research. OBJECTIVES This study outlines a new approach for improving the efficiency of natural product preparation, focusing on the rapid and accurate screening of potential active ingredients in Ganoderma lucidum and efficient preparation of lipoxidase inhibitors, with the aim of providing new ideas for the treatment of Alzheimer's disease with G. lucidum. METHODS The medicinal plant G. lucidum was selected through ultrafiltration coupled with liquid chromatography and mass spectrometry (UF-LC-MS) and computer-assisted screening for lipoxygenase (LOX) inhibitors. In addition, the inhibitory effect of the active compounds on LOX was studied using enzymatic reaction kinetics, and the underlying mechanism is discussed. Finally, based on the earlier activity screening guidelines, the identified ligands were isolated and purified through complex chromatography (high-speed countercurrent chromatography and semi-preparative high-performance liquid chromatography). RESULTS Five active ingredients, ganoderic acids A, B, C2, D2, and F, were identified and isolated from G. lucidum. We improved the efficiency and purity of active compound preparation using virtual computer screening and enzyme inhibition assays combined with complex chromatography. CONCLUSION The innovative methods of UF-LC-MS, computer-aided screening, and complex chromatography provide powerful tools for screening and separating LOX inhibitors from complex matrices and provide a favourable platform for the large-scale production of bioactive substances and nutrients.
Collapse
Affiliation(s)
- Yuyu Nong
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Xu Zhou
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Sainan Li
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Qiang Liu
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Yutong Zhang
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Jiaqi Liang
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Yuchi Zhang
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Chunming Liu
- Central Laboratory, Changchun Normal University, Changchun, China
| |
Collapse
|
6
|
Dai W, Li B, Xiong Y, Dai L, Tian Y, Zhang L, Wang Q, Qian G. Non-Volatile Component and Antioxidant Activity: A Comparative Analysis between Litsea cubeba Branches and Leaves. Molecules 2024; 29:788. [PMID: 38398540 PMCID: PMC10892920 DOI: 10.3390/molecules29040788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Revised: 02/02/2024] [Accepted: 02/06/2024] [Indexed: 02/25/2024] Open
Abstract
Litsea cubeba, which is found widely distributed across the Asian region, functions as both an economic tree and a medicinal plant with a rich historical background. Previous investigations into its chemical composition and biological activity have predominantly centered on volatile components, leaving the study of non-volatile components relatively unexplored. In this study, we employed UPLC-HRMS technology to analyze the non-volatile components of L. cubeba branches and leaves, which successfully resulted in identifying 72 constituents. Comparative analysis between branches and leaves unveiled alkaloids, organic acids, and flavonoids as the major components. However, noteworthy differences in the distribution of these components between branches and leaves were observed, with only eight shared constituents, indicating substantial chemical variations in different parts of L. cubeba. Particularly, 24 compounds were identified for the first time from this plant. The assessment of antioxidant activity using four methods (ABTS, DPPH, FRAP, and CUPRAC) demonstrated remarkable antioxidant capabilities in both branches and leaves, with slightly higher efficacy observed in branches. This suggests that L. cubeba may act as a potential natural antioxidant with applications in health and therapeutic interventions. In conclusion, the chemical composition and antioxidant activity of L. cubeba provides a scientific foundation for its development and utilization in medicine and health products, offering promising avenues for the rational exploitation of L. cubeba resources in the future.
Collapse
Affiliation(s)
- Wei Dai
- Teaching and Experimental Center, Guangdong Pharmaceutical University, Guangzhou 510006, China; (W.D.)
| | - Boyi Li
- School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China (Y.X.)
| | - Yanli Xiong
- School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China (Y.X.)
| | - Liping Dai
- Teaching and Experimental Center, Guangdong Pharmaceutical University, Guangzhou 510006, China; (W.D.)
| | - Yuan Tian
- Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832003, China
| | - Liangqian Zhang
- Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832003, China
| | - Qi Wang
- Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832003, China
| | - Guoqiang Qian
- School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China (Y.X.)
| |
Collapse
|
7
|
Hou W, Niu H, Liu Z, Zhang Y, Li S, Liu C. In-depth analysis of the xanthine oxidase inhibitors of Cicer arietinum L.-based receptor-ligand affinity coupled with complex chromatography. PHYTOCHEMICAL ANALYSIS : PCA 2023; 34:997-1008. [PMID: 37518935 DOI: 10.1002/pca.3267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 07/05/2023] [Accepted: 07/10/2023] [Indexed: 08/01/2023]
Abstract
INTRODUCTION Cicer arietinum L. is the choice of health food for people with diabetes, hypertension, and hyperlipidemia. As an essential source of high-nutrition legumes, it is also an important source of dietary isoflavones. OBJECTIVES In order to improve the preparation efficiency of natural plants, a rapid biological activity screening and preparation of xanthine oxidase inhibitors from C. arietinum L. was established. METHODS Xanthine oxidase (XOD) inhibitors were rapidly screened using ultrafiltration liquid chromatography-mass spectrometry (UF-LC-MS) based on receptor-ligand affinity. The change in XOD activity was evaluated by enzymatic reaction kinetics measurement. The potential bioactive compounds were verified through molecular docking. In addition, the biological activity of ligands screened was separated and purified by complex chromatography. The structures of the compounds were identified by nuclear magnetic resonance spectroscopy. RESULTS Three active ingredients, namely daidzin, daidzein, calycosin with XOD binding affinities were identified and isolated from the raw plant materials via semi-preparative high-performance liquid chromatography (HPLC), 0-60 min, 5-50% B and countercurrent chromatography (CCC) (ethyl acetate/acetic acid/water [5:0.8:10, v/v/v]). CONCLUSION This study will help to elucidate the mechanisms of action of natural plants of interest at the molecular level and could also provide more opportunities for the discovery and development of new nutritional value from other natural resources.
Collapse
Affiliation(s)
- Wanchao Hou
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Huazhou Niu
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Zhen Liu
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Yuchi Zhang
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Sainan Li
- Central Laboratory, Changchun Normal University, Changchun, China
| | - Chunming Liu
- Central Laboratory, Changchun Normal University, Changchun, China
| |
Collapse
|
8
|
Yang L, Zhai Y, Zhang Z, Liu Z, Hou B, Zhang B, Wang Z. Widely Targeted Metabolomics Reveals the Effects of Soil on the Metabolites in Dioscorea opposita Thunb. Molecules 2023; 28:4925. [PMID: 37446587 DOI: 10.3390/molecules28134925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 06/13/2023] [Accepted: 06/16/2023] [Indexed: 07/15/2023] Open
Abstract
Chinese yam (Dioscorea opposita Thunb. cv. Tiegun), a type of homologous medicinal plant, mainly grows in sandy soil (SCY) and loessial soil (LCY). However, the effects of the soil on the metabolites in SCY and LCY remain unclear. Herein, this study aims to comprehensively elucidate the metabolites in SCY and LCY. A UPLC-MS/MS-based, widely targeted metabolomics approach was adapted to compare the chemical composition of SCY and LCY. A total of 988 metabolites were detected, including 443 primary metabolites, 510 secondary metabolites, and 35 other compounds. Notably, 177 differential metabolites (classified into 12 categories) were identified between SCY and LCY; among them, 85.9% (152 differential metabolites) were upregulated in LCY. LCY significantly increased the contents of primary metabolites such as 38 lipids and 6 nucleotides and derivatives, as well as some secondary metabolites such as 36 flavonoids, 28 phenolic acids, 13 alkaloids, and 6 tannins. The results indicate that loessial soil can improve the nutritional and medicinal value of D. opposita.
Collapse
Affiliation(s)
- Lanping Yang
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| | - Yangyang Zhai
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| | - Zhenzhen Zhang
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| | - Zhenzhen Liu
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| | - Baohua Hou
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| | - Baobao Zhang
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| | - Zhenhui Wang
- College of Medicine, Henan Polytechnic University, Jiaozuo 454000, China
| |
Collapse
|
9
|
Chen J, Huang Q, He Z, Tan G, Zou Y, Xie J, Qian Z. Screening of Tyrosinase, Xanthine Oxidase, and α-Glucosidase Inhibitors from Polygoni Cuspidati Rhizoma et Radix by Ultrafiltration and HPLC Analysis. Molecules 2023; 28:molecules28104170. [PMID: 37241909 DOI: 10.3390/molecules28104170] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 05/12/2023] [Accepted: 05/16/2023] [Indexed: 05/28/2023] Open
Abstract
Polygoni Cuspidati Rhizoma et Radix (PCR), the rhizome and root of Polygonum cuspidatum Sieb. et Zucc., has been used as an herbal medicine for a long time. In this study, the ultrafiltration combined with high performance liquid chromatography (UF-HPLC) method was developed to screen tyrosinase (TYR), α-glucosidase (α-GLU), and xanthine oxidase (XOD) inhibitors from PCR. Firstly, the inhibitory activity of 50% methanol PCR extract on TYR, α-GLU, XOD, and acetylcholinesterase (ACHE) was tested. The extract showed a good inhibition on the enzymes, except for ACHE. Therefore, UF-HPLC experiments were carried out to screen TYR, α-GLU, and XOD inhibitors from PCR extract. Seven potential bioactive components were discovered, including methylgallate (1), 1,6-di-O-galloyl-D-glucose (2), polydatin-4'-O-D-glucoside (3), resveratrol-4'-O-D-glucoside (4), polydatin (5), malonyl glucoside resveratrol (6), and resveratrol-5-O-D-glucoside (7). Most of them were found as enzyme inhibitors from PCR for the first time, except polydatin (5), which had been reported as an α-GLUI in PCR in the literature. Finally, molecular docking analysis was applied to validate the interactions of these seven potential active components with the enzymes. Compounds 1-7 were proven as TYR inhibitors, compounds 2, 4-7 were identified as XOD inhibitors, and compounds 4-6 were confirmed as α-GLU inhibitors. In short, the current study provides a good reference for the screening of enzyme inhibitors through UF-HPLC, and provides scientific data for future studies of PCR.
Collapse
Affiliation(s)
- Jing Chen
- College of Medical Imaging Laboratory and Rehabilitation, Xiangnan University, Chenzhou 423000, China
| | - Qi Huang
- Dongguan HEC Cordyceps R&D Co., Ltd., Dongguan 523850, China
| | - Zhuobin He
- Dongguan HEC Cordyceps R&D Co., Ltd., Dongguan 523850, China
| | - Guoying Tan
- Dongguan HEC Cordyceps R&D Co., Ltd., Dongguan 523850, China
| | - Yuansheng Zou
- Dongguan HEC Cordyceps R&D Co., Ltd., Dongguan 523850, China
| | - Juying Xie
- College of Medical Imaging Laboratory and Rehabilitation, Xiangnan University, Chenzhou 423000, China
| | - Zhengming Qian
- College of Medical Imaging Laboratory and Rehabilitation, Xiangnan University, Chenzhou 423000, China
- Dongguan HEC Cordyceps R&D Co., Ltd., Dongguan 523850, China
| |
Collapse
|
10
|
Song D, Zhao H, Wang L, Wang F, Fang L, Zhao X. Ethanol extract of Sophora japonica flower bud, an effective potential dietary supplement for the treatment of hyperuricemia. FOOD BIOSCI 2023. [DOI: 10.1016/j.fbio.2023.102457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|